Defects in Coagulation Encountered in Small Animal Critical Care

被引：14
作者：
Brainard, Benjamin M. [1 ]
Brown, Andrew J. [2 ]
机构：
[1] Univ Georgia, Dept Small Anim Med & Surg, Athens, GA 30602 USA
[2] VetsNow Referral Hosp, Glasgow G3 7DA, Lanark, Scotland
来源：
VETERINARY CLINICS OF NORTH AMERICA-SMALL ANIMAL PRACTICE | 2011年 / 41卷 / 04期
关键词：
DIC; Disseminated intravascular coagulation; Antithrombin; Plasma; Heparin; DISSEMINATED INTRAVASCULAR COAGULATION; MOLECULAR-WEIGHT HEPARIN; FRESH-FROZEN PLASMA; ACTIVATED PROTEIN-C; VON-WILLEBRANDS-DISEASE; CANINE WHOLE-BLOOD; MULTIPLE ORGAN DYSFUNCTION; PLATELET-FUNCTION ANALYZER; ANTITHROMBIN-III ACTIVITY; FACTOR PATHWAY INHIBITOR;
D O I：
10.1016/j.cvsm.2011.04.001
中图分类号：
S85 [动物医学（兽医学）];
学科分类号：
0906 ;
摘要：
Critically ill small animals are at risk for developing coagulation abnormalities. The processes of inflammation and coagulation are intertwined, and severe inflammation can lead to disturbances of coagulation. Severe coagulation dysfunction is associated with increased morbidity and mortality. Pathophysiology, diagnosis, and treatment of coagulation dysfunction are discussed. Defects in coagulation in small animal patients are complex and a consensus on diagnosis and treatment has yet to be reached.
引用
收藏
页码：783 / +
页数：22
相关论文
共 157 条
  • [1] Efficacy and safety of tifacogin (recombinant tissue factor pathway inhibitor) in severe sepsis -: A randomized controlled trial
    Abraham, E
    Reinhart, K
    Opal, S
    Demeyer, I
    Doig, C
    Rodriguez, AL
    Beale, R
    Svoboda, P
    Laterre, PF
    Simon, S
    Light, B
    Spapen, H
    Stone, J
    Seibert, A
    Peckelsen, C
    De Deyne, C
    Postier, R
    Pettilä, V
    Sprung, CL
    Artigas, A
    Percell, SR
    Shu, V
    Zwingelstein, C
    Tobias, J
    Poole, L
    Stolzenbach, JC
    Creasey, AA
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 290 (02): : 238 - 247
  • [2] Time course of platelet counts in critically ill patients
    Akca, S
    Haji-Michael, P
    de Mendonça, A
    Suter, P
    Levi, M
    Vincent, JL
    [J]. CRITICAL CARE MEDICINE, 2002, 30 (04) : 753 - 756
  • [3] Alwood AJ, 2007, J VET INTERN MED, V21, P378, DOI 10.1892/0891-6640(2007)21[378:AEOLHI]2.0.CO
  • [4] 2
  • [5] BABSKI DA, 2010, J VET EMERG CRIT CAR, V20, pA1
  • [6] Prospective validation of the International Society of Thrombosis and Haemostasis scoring system for disseminated intravascular coagulation
    Bakhtiari, K
    Meijers, JCM
    de Jonge, E
    Levi, M
    [J]. CRITICAL CARE MEDICINE, 2004, 32 (12) : 2416 - 2421
  • [7] Disseminated intravascular coagulation in acute leukemia
    Barbui, T
    Falanga, A
    [J]. SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2001, 27 (06) : 593 - 604
  • [8] Bateman SW, 1999, J AM VET MED ASSOC, V215, P798
  • [9] Efficacy and safety of recombinant human activated protein C for severe sepsis.
    Bernard, GR
    Vincent, JL
    Laterre, P
    LaRosa, SP
    Dhainaut, JF
    Lopez-Rodriguez, A
    Steingrub, JS
    Garber, GE
    Helterbrand, JD
    Ely, EW
    Fisher, CJ
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (10) : 699 - 709
  • [10] Boller EM., 2009, Small Animal Critical Care Medicine, P459
12345678910